Invasive Zygomycosis in Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole Prophylaxis

This publication has 15 references indexed in Scilit:

• Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants
  New England Journal of Medicine, 2004
• Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis
  Antimicrobial Agents and Chemotherapy, 2003
• Mucormycosis (Zygomycosis) in a Heart-Kidney Transplant Recipient: Recovery after Posaconazole Therapy
  Clinical Infectious Diseases, 2003
• In Vivo Activity of Posaconazole againstMucorspp. in an Immunosuppressed-Mouse Model
  Antimicrobial Agents and Chemotherapy, 2002
• Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
  Clinical Infectious Diseases, 2002
• A Black Necrotic Skin Lesion in an Immunocompromised Patient
  Archives of Dermatology, 2000
• Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole
  The Journal of Infectious Diseases, 2000
• Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation
  Bone Marrow Transplantation, 1999
• The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients
  Medicine, 1998
• Disseminated Zygomycosis in a Neutropenic Patient: Successful Treatment with Amphotericin B Lipid Complex and Granulocyte Colony-Stimulating Factor
  Clinical Infectious Diseases, 1997